The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
SDI are featured in a new article by Mike Tubbs about the thriving scientific instruments sector and the companies therein - SDI are by far the smallest company mentioned (apart from Kromek, who I'd steer clear from at their current valuation, though I'm also invested in EKF which is the next smallest to SDI):
Https://moneyweek.com/investments/stocks-and-shares/share-tips/602992/scientific-instrument-companies-are-a-global
"Scientific-instrument companies are a global success – here's how to play them
Companies delivering scientific instruments – products to measure and analyse our world – are crucial to sectors ranging from telecommunications to pharmaceuticals. Dr Mike Tubbs picks his favourite stocks in the sector.
26 Mar 2021
etc"
Nice coverage from John Rosier in his portfolio update in Friday's IC:
Https://www.investorschronicle.co.uk/ideas/2021/03/12/what-the-big-reopening-will-mean/
"My exposure to commodities was the main driver of performance in February, but the standout winner was SDI Group (SDI), the scientific instrument's manufacturer. It was up 57.2 per cent following a very bullish trading update. It said it expected revenue for the year ending 30 April to be up 38 per cent on last year to £38m and for April 2022, up a further 24 per cent to not less than £42m. This new guidance compared with previous forecasts of £32.8m and £35.3m respectively. SDI expected adjusted pre-tax profits for April 2021 and 2022 to be not less than £6.7m and £8.7m compared to forecasts of £5.8m and £6.8m. That's a massive 42 per cent increase in guidance for the year ending April 2022, and that's before the positive effect of further acquisitions."
Very nice article from SDI subsidiary Atik about their COVID-19 involvement - the last paragraph re working with more potential partners and developing the next generation of PCR testing instruments sounds exciting:
Https://www.atik-cameras.com/news/atik-secures-multiple-new-contracts-with-leading-global-pcr-manufacturers/
"Atik secures multiple new contracts with leading global PCR manufacturers
By Lewis Brown on March 3rd, 2021
We are delighted to announce that we have further expanded our collaboration with leading global Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.
Under the new agreements, OEMs will access our robust range of off-the-shelf and customised charge-coupled-device (CCD) and complementary metal oxide semiconductor (CMOS) cameras that are ideal for use with PCR instruments. The company’s commercially-competitive VS series of scientific CCD cameras offer superior sensitivity and image quality, and are now proven across thousands of PCR installations. Furthermore, the Advanced CMOS Imaging Systems (ACIS) series has also been recognised as a camera suitable for meeting the imaging needs of PCR applications.
In part due to the new contracts, Atik Cameras’ parent company, the SDI Group, which is listed on the LSE Alternative Investment Market (AIM) and focuses on the design and manufacture of scientific and technology products for use in digital imaging as well as sensing and control applications, anticipates it will exceed its initial expectations for the financial year ending on 30 April 2021. In response, Ken Ford, Chairman of the SDI Group, comments: “We are very pleased that our Atik Cameras business unit has secured follow-on camera orders from OEM manufacturers of real time PCR DNA amplifiers for delivery by 30 April 2022. This is a significant endorsement of Atik Cameras’ design and production capabilities, in recognition of its strong expertise in delivering powerful, dependable imaging solutions for the life science industry.”
To further grow and strengthen our production capability, and facilitate increased delivery of products for PCR experiments, we have expanded our ISO 9001 manufacturing facilities to enable us to work with more potential partners. Importantly, we are investing additional resources into the advancement of PCR technology, as we are wroking with customers to develop the next generation of PCR instruments, with the aim of increasing processing speed and throughput."
JP Morgan now have just over 5m shares:
Https://www.investegate.co.uk/sdi-group-plc--sdi-/rns/holding-s--in-company/202103021653519232Q/
Looks like they're buying from Bennbridge, who are doing a bit of top-slicing per their own RNS just out.
...and two very large buys this morning at 172p of 365k and 375k shares respectively. A good sign.....
Another article on Atik's growing OEM contracts re PCR testing cameras:
Https://www.med-technews.com/news/Covid-19-Medtech-News/imaging-specialist-expands-collaboration-with-oems-for-pcr-d/
"Imaging specialist expands collaboration with OEMs for PCR DNA amplifiers
26 February 2021
Atik Cameras, a designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply cameras for reliable COVID-19 testing.
Under the new agreements, OEMs will access Atik Cameras’ range of off-the-shelf and customised charge-coupled-device (CCD) and complementary metal oxide semiconductor (CMOS) cameras that are ideal for use with PCR instruments. The company’s commercially competitive VS series of scientific CCD cameras offer high sensitivity and image quality and are proven across thousands of PCR installations. Furthermore, Atik Cameras’ Advanced CMOS Imaging Systems (ACIS) series has also been recognised as a camera suitable for meeting the imaging needs of PCR applications.
In part due to the new contracts, Atik Cameras’ parent company, the SDI Group, which is listed on the LSE Alternative Investment Market (AIM) and focusses on the design and manufacture of scientific and technology products for use in digital imaging as well as sensing and control applications, anticipates it will exceed its initial expectations for the financial year ending on 30 April 2021.
Ken Ford, chairman of the SDI Group, said: “We are very pleased that our Atik Cameras business unit has secured follow-on camera orders from OEM manufacturers of real time PCR DNA amplifiers for delivery by 30 April 2022. This is a significant endorsement of Atik Cameras’ design and production capabilities, in recognition of its strong expertise in delivering powerful, dependable imaging solutions for the life science industry.”
To further grow and strengthen its production capability, and facilitate increased delivery of products for PCR experiments, Atik Cameras has expanded its ISO 9001 manufacturing facilities to enable the company to work with more potential partners. The company is investing additional resources into the advancement of PCR technology, working with customers to develop the next generation of PCR instruments, with the aim of increasing processing speed and throughput."
Https://www.med-technews.com/news/Covid-19-Medtech-News/imaging-specialist-expands-collaboration-with-oems-for-pcr-d/
"Imaging specialist expands collaboration with OEMs for PCR DNA amplifiers
26 February 2021
Atik Cameras, a designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply cameras for reliable COVID-19 testing.
Under the new agreements, OEMs will access Atik Cameras’ range of off-the-shelf and customised charge-coupled-device (CCD) and complementary metal oxide semiconductor (CMOS) cameras that are ideal for use with PCR instruments. The company’s commercially competitive VS series of scientific CCD cameras offer high sensitivity and image quality and are proven across thousands of PCR installations. Furthermore, Atik Cameras’ Advanced CMOS Imaging Systems (ACIS) series has also been recognised as a camera suitable for meeting the imaging needs of PCR applications.
In part due to the new contracts, Atik Cameras’ parent company, the SDI Group, which is listed on the LSE Alternative Investment Market (AIM) and focusses on the design and manufacture of scientific and technology products for use in digital imaging as well as sensing and control applications, anticipates it will exceed its initial expectations for the financial year ending on 30 April 2021.
Ken Ford, chairman of the SDI Group, said: “We are very pleased that our Atik Cameras business unit has secured follow-on camera orders from OEM manufacturers of real time PCR DNA amplifiers for delivery by 30 April 2022. This is a significant endorsement of Atik Cameras’ design and production capabilities, in recognition of its strong expertise in delivering powerful, dependable imaging solutions for the life science industry.”
To further grow and strengthen its production capability, and facilitate increased delivery of products for PCR experiments, Atik Cameras has expanded its ISO 9001 manufacturing facilities to enable the company to work with more potential partners. The company is investing additional resources into the advancement of PCR technology, working with customers to develop the next generation of PCR instruments, with the aim of increasing processing speed and throughput."
Bargain time here imho. Today's drop is only due to SCSW stating on the weekend that they were taking part-profits - but they're only saying this in the context of the "breathtaking" 710% rise since they tipped SDI, and to raise a bit of cash for their portfolio by top-slicing.
So a few have been blindly following their actions this morning. But some of us have been here since 8.5p/9p and are still holding confidently.....and the price has already begun to recover.
I'm resisting taking just a little profit but it is getting quite hard !! Such a great story...and co..
New article from Atik Cameras about their role in COVID-19 PCR testing(not posted before):
Https://www.atik-cameras.com/news/pcr-solutions-sdi/
"Atik’s solutions for PCR help to provide positive outlook for SDI Group
Both prior to and throughout the COVID-19 pandemic, Atik Cameras has provided imaging solutions for real time PCR DNA amplifiers.
Of course, this has been a major source of pride for Atik from a humanitarian perspective. It is also the case that this has provided a positive contribution to Atik’s parent company, the SDI Group plc.
In part due to Atik and its imaging solutions for PCR, the SDI Group, which is listed on the LSE Alternative Investment Market (AIM) and focuses on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, is expecting to exceed its initial expectations for its financial year ending 30 April 2021.
This news has prompted Ken Ford, the Chairman of SDI to comment, “This is a significant endorsement of the Atik Camera design and production capability, recognising its expertise in imaging solutions for life sciences.”
Atik are delighted to continue to provide solutions for PCR, with our bespoke VS825 now being used in thousands of settings worldwide. The VS825 is a modified camera that showcases Atik’s flexible design philosophy and the ability to transfer expertise across domains to produce high quality, cost-effective customised solutions.
Furthermore, the ACIS series is also very well suited for use in PCR applications, featuring a selection of Sony CMOS sensors with fully customisable hardware and software options. The cameras in this series can be applied in a variety of different manners and to a wide range of projects.
Of course, PCR is simply one of the many applications that Atik Cameras can support, you can see more examples of the supported applications here. Additionally, you can view the recent webinar on imaging solutions in Life Sciences below."
Hi I’ve picked SDI as a possible company that I’d like to invest in. It’s got a great history of growing revenue, profit, earnings without need to dilute shareholders and I can see the recent trading updates suggest growth is to continue through 21/22. I wonder if any long term holders can explain whether the share has more broader appeal beyond 2022?
Sorry for the repeat, it must have just got delayed.
Really annoying, posts just disappear. As I was saying....
I'd love to see them get together with IQ-AI. The combination of their top flight imaging with the AI could be really interesting.
I'd love to see them get together with IQ-AI. The combination of the top level imaging with the AI would be really interesting.
Partly due I suspect to a huge 515,000 share buy earlier this morning at 165p.
Impressive news from SDI's Chell Instruments:
Https://www.chell.co.uk/news
"08.02.21
Chell Instruments Celebrate Smallest, Fastest and Most Accurate Range Ever
World-renowned gas measurement and control experts, Chell Instruments, have announced their MicroDaq, nanoDaq and nanoDaq-LT range now features the smallest, fastest and most accurate pressure scanners available on the market.
With over 25 products, Chell’s range now features products which they believe achieve the highest specifications in many categories. With more than four decades of development, the full scanner range has been designed to meet pressure scanning challenges in industries including aerospace and motorsport.
Nick Broadley, Managing Director of Chell Instruments, says “We’re thrilled to have developed our complete scanner range to include the smallest, fastest and most accurate pressure scanners on the market. All our products are designed for the very best performance and manufactured right here in the UK. It’s a testament to our engineering team that we’ve developed such a comprehensive range of products which lead in so many areas!”
Chell’s nanoDAQ-LTC-16 is the smallest available on the market. The compact pressure scanner measures only 50mm by 23mm by 9mm but has the same advanced calibration and thermal compensation as the rest of the nanoDaq-LT range. The intelligent scanner’s compact size means it can be used in challenging applications and environments with limited space and access.
Chell’s nanoDAQ32 holds the prestigious accolade of being the fastest pressure scanner available on the market. The miniature pressure scanner can produce fully compensated engineering unit data at a frequency of 4kHz per channel. Combined with its compact size, it makes it a powerful tool for dynamic applications such as wind-tunnel testing.
In addition, Chell’s microDAQ is still the benchmark for high accuracy pressure data acquisition. The ‘single box solution’ provides complete pressure scanning with outputs of over Ethernet and CAN. However, it does so with an accuracy level of better than 0.05% of full scale.
etc"
Hi Rivaldo. My son moved to Portugal [an hour outside Lisbon],last august. CV has been terrible there since the second wave went thro'. When people moan about govt. restriction here , my son was under curfew from 1pm each day,so what SDI have achieved whil'st working under that situation,is truly remarkable. One idea that crosses my mind, is in light of all the 'red tape' incurred since brexit,does having an EU location,for a major part of the business help with european sales ? cheers stay safe Tony
Apart from everything else, the AutoCOL colony counting system from Synoptics sounds particularly exciting, with "interest from 4 of the top 10 Pharma companies".
And the Uniform Engineering acquisition is yet another example of how SDI are not just a buy and build operation, but use their acquisitions to turbo-charge organic growth:
"Within the group we have four businesses that use metal fabrication which is part of the virtual chain, so it makes absolute sense to use our own facility, whilst also extending its reach”".
Https://martinflitton1.wixsite.com/privatepunter/post/sdi-group-in-rude-health-10-02-21
Up 20%, great news all round.
GLA
Finncap have raised their target price to 180p (from 130p) following the "ahead" trading statement.
They've also raised their forecasts to 5.5p EPS for this year ending 30th April, and 7.1p EPS for the coming year.
And they also conclude that there's additional upside from that 180p given that JDG and Halma still trade on higher multiples than SDI would be on at 180p........
Excellent. As I said before 200p in the next year looks likely. If they make 9m in 2022 I would expect a market cap of 300m against 118m now
Wow....
SDI now expect PBT for this year to 30th April to be at least 22% above forecasts - and PBT for next year to be at least 50% above forecasts!
Atik is obviously behind some of this, but "also underpinned by the continued recovery of activity across all of its businesses".
Given that SDI are naturally so prudent, we can be pretty sure that these numbers are nailed on.
Stunning:
https://uk.advfn.com/stock-market/london/sdi-SDI/share-news/SDI-Group-PLC-Trading-Update/84290648
Good to see Atik capitalising on their involvement in fighting COVID-19 with a webinar and a new primer explaining the necessity for imaging solutions:
Https://www.atik-cameras.com/news/exploring-imaging-solutions-in-life-science/
after today's acquisition news.
Smaa but perfectly formed. Looks a bargain at £0.35m for £1m turnover and £0.1m PBT, plus all the synergies which can be expected from cross-selling etc:
Https://uk.advfn.com/stock-market/london/sdi-SDI/share-news/SDI-Group-PLC-Acquisition-of-Uniform-Engineering/84209903
perkylad & rivaldo - thanks both :-)